Phathom Pharmaceuticals, Inc.
PHAT
$10.48
$0.100.96%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 17.10% | -13.84% | 6.43% | -97.90% | -123.23% |
| Total Depreciation and Amortization | -12.69% | -17.29% | 4.32% | 57.85% | 60.16% |
| Total Amortization of Deferred Charges | 46.80% | 46.84% | 11.13% | 8.67% | 83.15% |
| Total Other Non-Cash Items | -12.24% | -13.58% | -44.07% | 51.70% | 48.18% |
| Change in Net Operating Assets | -850.64% | -26.96% | -1,436.69% | 157.42% | -114.13% |
| Cash from Operations | 11.30% | -23.05% | -44.89% | -99.20% | -218.56% |
| Capital Expenditure | -110.87% | 55.00% | 98.95% | 95.31% | -666.67% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -110.87% | 55.00% | 98.95% | 95.31% | -666.67% |
| Total Debt Issued | -- | -- | -88.33% | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 280.95% | -- | -- | 938,800.00% | -99.99% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -99.68% | -- | -87.71% | 938,800.00% | -82.49% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -36.42% | -43.59% | -122.31% | 277.95% | -138.56% |